Implantation of Porous Titanium Prosthesis in Laryngeal Surgery
1 other identifier
interventional
10
1 country
1
Brief Summary
This study evaluates a medialization implant to treat vocal cord paralysis, to permit it to adjust the quality of the voice under local or general anesthesia. The aim is to restore phonation using a porous titanium prosthesis in laryngeal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Dec 2010
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedJuly 2, 2012
June 1, 2012
5.4 years
September 13, 2005
June 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Nasofibroscopy
8 days and 3 months after surgery
Voice control and recording
8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
All types of complication
8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
Interventions
The porous titanium prosthesis is implanted under local anaesthesia. Neck incision is performed in order to expose the thyroidal cartilage. A window is then opened in this cartilage, and the implant is placed in contact with the vocal muscles. The patient is then asked to speak in order to achieve the implant best setting.
Eligibility Criteria
You may qualify if:
- Males or females greater than 18 years old
You may not qualify if:
- Age less than 18 years
- Pregnant women
- Local carcinoma excluding radiotherapeutic or surgical control
- Bad general condition
- Contraindication to general anesthesia
- Non-controlled diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre
Strasbourg, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Debry, MD
Hopitaux Universitaires de Strasbourg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
December 1, 2010
Primary Completion
May 1, 2016
Study Completion
November 1, 2016
Last Updated
July 2, 2012
Record last verified: 2012-06